SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Samsung Biologics to buy Swiss contract development and manufacturing organization

Samsung Biologics plans to buy a Swiss contract development and manufacturing organization.

PPGN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.